{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:34:56Z","timestamp":1786991696402,"version":"build-2736575974"},"reference-count":148,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["canadianjournalofdiabetes.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Diabetes"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jcjd.2023.08.003","type":"journal-article","created":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T01:12:48Z","timestamp":1696900368000},"page":"548-559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Hypoglycemia in Adults"],"prefix":"10.1016","volume":"47","author":[{"given":"Iliana C.","family":"Lega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Yale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayush","family":"Chadha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Breay","family":"Paty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Roscoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Snider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Steier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harpreet S.","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Honshorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"MacKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Mansell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Senior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doreen","family":"Rabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Sherifali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjd.2023.08.003_bib1","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2337\/dc16-0985","article-title":"Trends in drug utilization, glycemic control, and rates of severe hypoglycemia, 2006\u20132013","volume":"40","author":"Lipska","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib2","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00125-020-05370-7","article-title":"Potential diabetes overtreatment and risk of adverse events among older adults in Ontario: A population-based study","volume":"64","author":"Lega","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcjd.2023.08.003_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.19099","article-title":"Association of cumulative multimorbidity, glycemic control, and medication use with hypoglycemia-related emergency department visits and hospitalizations among adults with diabetes","volume":"3","author":"McCoy","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jcjd.2023.08.003_bib4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1477-7525-8-86","article-title":"Association of hypoglycemic symptoms with patients\u2019 rating of their health-related quality of life state: A cross sectional study","volume":"8","author":"Alvarez-Guisasola","year":"2010","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jcjd.2023.08.003_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108752","article-title":"The impact of hypoglycaemia on quality of life outcomes among adults with type 1 diabetes: A systematic review","volume":"174","author":"Chatwin","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jcjd.2023.08.003_bib6","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1464-5491.2010.03078.x","article-title":"Fear of hypoglycaemia in adults with type 1 diabetes","volume":"27","author":"Anderbro","year":"2010","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcjd.2023.08.003_bib7","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1177\/1742395309346464","article-title":"Beliefs about insulin as a predictor of fear of hypoglycaemia","volume":"5","author":"Belendez","year":"2009","journal-title":"Chronic Illn"},{"key":"10.1016\/j.jcjd.2023.08.003_bib8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-2431-10-50","article-title":"Fear of hypoglycaemia in parents of young children with type 1 diabetes: A systematic review","volume":"10","author":"Barnard","year":"2010","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.jcjd.2023.08.003_bib9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/0145721709333492","article-title":"Type 1 diabetes among adolescents: Reduced diabetes self-care caused by social fear and fear of hypoglycemia","volume":"35","author":"Di Battista","year":"2009","journal-title":"Diabetes Educ"},{"key":"10.1016\/j.jcjd.2023.08.003_bib10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1464-5491.2009.02867.x","article-title":"Fear of hypoglycaemia in mothers and fathers of children with type 1 diabetes is associated with poor glycaemic control and parental emotional distress: A population-based study","volume":"27","author":"Haugstvedt","year":"2010","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcjd.2023.08.003_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2017-000503","article-title":"Real-world crude incidence of hypoglycemia in adults with diabetes: Results of the InHypo-DM Study, Canada","volume":"6","author":"Ratzki-Leewing","year":"2018","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.863184","article-title":"The role of GLP-1 signaling in hypoglycemia due to hyperinsulinism","volume":"13","author":"Danowitz","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jcjd.2023.08.003_bib13","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.931311","article-title":"Symptomatic hypoglycemia during treatment with a therapeutic dose of metformin","volume":"22","author":"Joseph","year":"2021","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.jcjd.2023.08.003_bib14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2337\/dc16-2215","article-title":"Glucose concentrations of less than 3.0 mmol\/L (54\u00a0mg\/dL) should be reported in clinical trials: A joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"40","year":"2017","journal-title":"Diabetes Care"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2023.08.003_bib15","first-page":"S83","article-title":"6. Glycemic targets: Standards of medical care in diabetes---2022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib16","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.2337\/diab.43.11.1378","article-title":"Banting Lecture. Hypoglycemia: The limiting factor in the management of IDDM","volume":"43","author":"Cryer","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.jcjd.2023.08.003_bib17","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2337\/diacare.18.11.1415","article-title":"Adverse events and their association with treatment regimens in the diabetes control and complications trial","volume":"18","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2337\/diab.46.2.271","article-title":"Hypoglycemia in the diabetes control and complications trial","volume":"46","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.jcjd.2023.08.003_bib19","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1007\/s001250051065","article-title":"Risk factors of severe hypoglycaemia in adult patients with type I diabetes---a prospective population based study","volume":"41","author":"M\u00fchlhauser","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcjd.2023.08.003_bib20","doi-asserted-by":"crossref","first-page":"b5444","DOI":"10.1136\/bmj.b5444","article-title":"The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: Post hoc epidemiological analysis of the ACCORD study","volume":"340","author":"Miller","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.jcjd.2023.08.003_bib21","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0002-9343(91)80085-Z","article-title":"Epidemiology of severe hypoglycemia in the diabetes control and complications trial","volume":"90","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.jcjd.2023.08.003_bib22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2337\/diacare.20.1.22","article-title":"Hypoglycemia: Incidence and clinical predictors in a large population-based sample of children and adolescents with IDDM","volume":"20","author":"Davis","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib23","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/(SICI)1096-9136(199711)14:11<919::AID-DIA456>3.0.CO;2-A","article-title":"Risk of adverse effects of intensified treatment in insulin-dependent diabetes mellitus: A meta-analysis","volume":"14","author":"Egger","year":"1997","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcjd.2023.08.003_bib24","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1210\/jc.2009-2828","article-title":"Determinants of severe hypoglycemia complicating type 2 diabetes: The Fremantle Diabetes Study","volume":"95","author":"Davis","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jcjd.2023.08.003_bib25","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2337\/diacare.17.7.697","article-title":"Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia","volume":"17","author":"Gold","year":"1994","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib26","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.diabres.2009.10.013","article-title":"Prevalence of impaired awareness of hypoglycaemia and frequency of hypoglycaemia in insulin-treated type 2 diabetes","volume":"87","author":"Schopman","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jcjd.2023.08.003_bib27","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2337\/diacare.17.12.1397","article-title":"Hypoglycemia unawareness in IDDM","volume":"17","author":"Mokan","year":"1994","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib28","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.2337\/diacare.21.11.1960","article-title":"Effects of autonomic neuropathy on counterregulation and awareness of hypoglycemia in type 1 diabetic patients","volume":"21","author":"Meyer","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-3476(94)70190-3","article-title":"Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial","volume":"125","year":"1994","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jcjd.2023.08.003_bib30","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1007\/s00125-009-1484-7","article-title":"Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: The Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial","volume":"52","author":"de Galan","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcjd.2023.08.003_bib31","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2337\/dc11-1855","article-title":"ACCORD Group of Investigators; ACCORD-MIND Investigators. Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: Post hoc epidemiologic analysis of the ACCORD trial","volume":"35","author":"Punthakee","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib32","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/s11606-010-1389-7","article-title":"Hypoglycemia is more common among type 2 diabetes patients with limited health literacy: The Diabetes Study of Northern California (DISTANCE)","volume":"25","author":"Sarkar","year":"2010","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.jcjd.2023.08.003_bib33","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1353\/hpu.2010.0921","article-title":"Food insecurity is associated with hypoglycemia and poor diabetes self-management in a low-income sample with diabetes","volume":"21","author":"Seligman","year":"2010","journal-title":"J\u00a0Health Care Poor Underserved"},{"key":"10.1016\/j.jcjd.2023.08.003_bib34","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1007\/s00125-007-0599-y","article-title":"UK Hypoglycaemia Study Group. Risk of hypoglycaemia in types 1 and 2 diabetes: Effects of treatment modalities and their duration","volume":"50","author":"Heller","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcjd.2023.08.003_bib35","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.2337\/dc17-1834","article-title":"Patient characteristics associated with severe hypoglycemia in a type 2 diabetes cohort in a large, integrated health care system from 2006 to 2015","volume":"41","author":"Misra-Hebert","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib36","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1001\/jamainternmed.2017.3844","article-title":"Development and validation of a tool to identify patients with type 2 diabetes at high risk of hypoglycemia-related emergency department or hospital use","volume":"177","author":"Karter","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jcjd.2023.08.003_bib37","doi-asserted-by":"crossref","first-page":"912","DOI":"10.4239\/wjd.v6.i7.912","article-title":"Mechanisms of hypoglycemia unawareness and implications in diabetic patients","volume":"6","author":"Mart\u00edn-Tim\u00f3n","year":"2015","journal-title":"World J Diabetes"},{"key":"10.1016\/j.jcjd.2023.08.003_bib38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13098-023-01024-x","article-title":"Protective and risk factors of impaired awareness of hypoglycemia in patients with type 1 diabetes: A cross-sectional analysis of baseline data from the PR-IAH study","volume":"15","author":"Sakane","year":"2023","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.jcjd.2023.08.003_bib39","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2337\/diacare.18.4.517","article-title":"Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms","volume":"18","author":"Clarke","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib40","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1262-3636(07)70191-X","article-title":"Identification of factors associated with impaired hypoglycaemia awareness in patients with type 1 and type 2 diabetes mellitus","volume":"31","author":"Berlin","year":"2005","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jcjd.2023.08.003_bib41","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1371\/journal.pmed.0040069","article-title":"Defective awakening response to nocturnal hypoglycemia in patients with type 1 diabetes mellitus","volume":"4","author":"Schultes","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.jcjd.2023.08.003_bib42","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/adc.75.2.120","article-title":"Nocturnal hypoglycaemia and sleep disturbances in young teenagers with insulin dependent diabetes mellitus","volume":"75","author":"Porter","year":"1996","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jcjd.2023.08.003_bib43","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(79)92950-7","article-title":"Unrecognised nocturnal hypoglycaemia in insulin-treated diabetics","volume":"i","author":"Gale","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.jcjd.2023.08.003_bib44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0022-3476(97)70121-5","article-title":"Nocturnal hypoglycemia in children and adolescents with insulin-dependent diabetes mellitus: Prevalence and risk factors","volume":"131","author":"Beregsz\u00e0szi","year":"1997","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jcjd.2023.08.003_bib45","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/(SICI)1096-9136(199609)13:9<794::AID-DIA185>3.0.CO;2-G","article-title":"Nocturnal blood glucose profiles in patients with type 1 diabetes mellitus on multiple (> or\u00a0= 4) daily insulin injection regimens","volume":"13","author":"Vervoort","year":"1996","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcjd.2023.08.003_bib46","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.physbeh.2010.01.004","article-title":"Mini-review: Impact of recurrent hypoglycemia on cognitive and brain function","volume":"100","author":"McNay","year":"2010","journal-title":"Physiol Behav"},{"key":"10.1016\/j.jcjd.2023.08.003_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.571568","article-title":"Meta-analysis: Association between hypoglycemia and serious adverse events in older patients treated with glucose-lowering agents","volume":"12","author":"Mattishent","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jcjd.2023.08.003_bib48","doi-asserted-by":"crossref","first-page":"e1976","DOI":"10.1210\/clinem\/dgab860","article-title":"Severe hypoglycemia increases dementia risk and related mortality: A nationwide, population-based cohort study","volume":"107","author":"Han","year":"2022","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jcjd.2023.08.003_bib49","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1007\/s00125-009-1437-1","article-title":"Severe hypoglycaemia and cognitive impairment in older patients with diabetes: The Fremantle Diabetes Study","volume":"52","author":"Bruce","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcjd.2023.08.003_bib50","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.2337\/dc14-0973","article-title":"Effect of hypoglycemia on brain structure in people with type 2 diabetes: Epidemiological analysis of the ACCORDMIND MRI trial","volume":"37","author":"Zhang","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib51","doi-asserted-by":"crossref","first-page":"379","DOI":"10.7326\/0003-4819-124-4-199602150-00001","article-title":"Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial","volume":"124","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcjd.2023.08.003_bib52","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2337\/diab.43.2.313","article-title":"Mortality and treatment side-effects during long-term intensified conventional insulin treatment in the Stockholm Diabetes Intervention Study","volume":"43","author":"Reichard","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.jcjd.2023.08.003_bib53","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJMoa066397","article-title":"Long-term effect of diabetes and its treatment on cognitive function","volume":"356","author":"Jacobson","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcjd.2023.08.003_bib54","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S2213-8587(21)00086-3","article-title":"Cognitive performance declines in older adults with type 1 diabetes: Results from 32 years of follow-up in the DCCT and EDIC Study","volume":"9","author":"Jacobson","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jcjd.2023.08.003_bib55","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1056\/NEJMoa1414266","article-title":"Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes","volume":"372","author":"Hayward","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcjd.2023.08.003_bib56","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1056\/NEJMoa1003795","article-title":"Severe hypoglycemia and risks of vascular events and death","volume":"363","author":"Zoungas","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcjd.2023.08.003_bib57","doi-asserted-by":"crossref","first-page":"b4909","DOI":"10.1136\/bmj.b4909","article-title":"The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: Retrospective epidemiological analysis of the ACCORD study","volume":"340","author":"Bonds","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.jcjd.2023.08.003_bib58","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2337\/dc08-9026","volume":"32","author":"Skyler","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib59","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2337\/dc10-0013","article-title":"Effects of acute insulin-induced hypoglycemia on indices of inflammation: Putative mechanism for aggravating vascular disease in diabetes","volume":"33","author":"Wright","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib60","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.2337\/dc09-0354","article-title":"Effects of acute hypoglycemia on inflammatory and pro-atherothrombotic biomarkers in individuals with type 1 diabetes and healthy individuals","volume":"33","author":"Gogitidze Joy","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib61","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00125-007-0902-y","article-title":"Effects of controlled hypoglycaemia on cardiac repolarisation in patients with type 1 diabetes","volume":"51","author":"Koivikko","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcjd.2023.08.003_bib62","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/dia.2009.0153","article-title":"Continuous glucose monitoring reveals associations of glucose levels with QT interval length","volume":"12","author":"Kubiak","year":"2010","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jcjd.2023.08.003_bib63","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/dmrr.865","article-title":"Vascular disease and diabetes: Is hypoglycaemia an aggravating factor?","volume":"24","author":"Wright","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"issue":"Suppl. 2","key":"10.1016\/j.jcjd.2023.08.003_bib64","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.2337\/dc11-s220","article-title":"Hypoglycemia and cardiovascular risks","volume":"34","author":"Frier","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib65","doi-asserted-by":"crossref","first-page":"516","DOI":"10.2337\/dc13-0600","article-title":"Relationship between hypoglycemic episodes and ventricular arrhythmias in patients with type 2 diabetes and cardiovascular diseases: Silent hypoglycemias and silent arrhythmias","volume":"37","author":"Stahn","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib66","doi-asserted-by":"crossref","first-page":"E240","DOI":"10.1152\/ajpendo.00442.2017","article-title":"Severe hypoglycemia-induced sudden death is mediated by both cardiac arrhythmias and seizures","volume":"315","author":"Reno","year":"2018","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jcjd.2023.08.003_bib67","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2021-002322","article-title":"\u2018Never again will I be carefree\u2019: A qualitative study of the impact of hypoglycemia on quality of life among adults with type 1 diabetes","volume":"9","author":"Chatwin","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib68","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.2337\/diacare.28.11.2662","article-title":"The impact of diabetes on employment and work productivity","volume":"28","author":"Tunceli","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib69","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/j.1464-5491.2008.02533.x","article-title":"A\u00a0longitudinal study of affective and anxiety disorders, depressive affect and diabetes distress in adults with type 2 diabetes","volume":"25","author":"Fisher","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcjd.2023.08.003_bib70","doi-asserted-by":"crossref","first-page":"542","DOI":"10.2337\/dc06-1614","article-title":"Clinical depression versus distress among patients with type 2 diabetes: Not just a question of semantics","volume":"30","author":"Fisher","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib71","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2337\/dc09-1238","article-title":"Diabetes distress but not clinical depression or depressive symptoms is associated with glycemic control in both cross-sectional and longitudinal analyses","volume":"33","author":"Fisher","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib72","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2337\/dc10-1970","article-title":"Depression in diabetes: Have we been missing something important?","volume":"34","author":"Gonzalez","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib73","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1007\/s13300-019-00687-y","article-title":"Family members: The forgotten players in the diabetes care team (the TALK-HYPO Study)","volume":"10","author":"Ratzki-Leewing","year":"2019","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.jcjd.2023.08.003_bib74","doi-asserted-by":"crossref","first-page":"P403","DOI":"10.1016\/j.jcjd.2020.08.098","article-title":"When low blood sugars cause high anxiety: Fear of hypoglycemia among parents of youth with type 1 diabetes mellitus","volume":"45","author":"Abitbol","year":"2021","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2023.08.003_bib75","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s11136-012-0234-3","article-title":"Non-severe nocturnal hypoglycemic events: Experience and impacts on patient functioning and well-being","volume":"22","author":"Brod","year":"2013","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jcjd.2023.08.003_bib76","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2023-003394","article-title":"Prevalence of fear of hypoglycemia in adults with type 1 diabetes using a newly developed screener and clinician\u2019s perspective on its implementation","volume":"11","author":"Peter","year":"2023","journal-title":"BMJ Open Diab Res Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib77","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/dc13-0971","article-title":"Toward defining a cutoff score for elevated fear of hypoglycemia on the hypoglycemia fear survey worry subscale in patients with type 2 diabetes","volume":"37","author":"Haj\u00f3s","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib78","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2633","article-title":"Fear of hypoglycemia---an underestimated problem","volume":"12","author":"Przezak","year":"2022","journal-title":"Brain Behav"},{"key":"10.1016\/j.jcjd.2023.08.003_bib79","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jcjd.2021.04.008","article-title":"Acceptability of self-management group education to reduce fear of hypoglycemia as a barrier to physical activity in adults with type 1 diabetes: A mixed methods approach","volume":"46","author":"Brennan","year":"2022","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2023.08.003_bib80","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.2337\/diacare.22.7.1022","article-title":"Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes","volume":"22","author":"Kinsley","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib81","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10865-005-9026-3","article-title":"Randomized controlled clinical trial of Blood Glucose Awareness Training (BGAT III) in Switzerland and Germany","volume":"28","author":"Schachinger","year":"2005","journal-title":"J\u00a0Behav Med"},{"key":"10.1016\/j.jcjd.2023.08.003_bib82","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.2337\/dc15-0102","article-title":"Interventions that restore awareness of hypoglycemia in adults with type 1 diabetes: A systematic review and meta-analysis","volume":"38","author":"Yeoh","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib83","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/ndt\/gfs613","article-title":"Mortality in diabetes: Pancreas transplantation is associated with significant survival benefit","volume":"28","author":"van Dellen","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jcjd.2023.08.003_bib84","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.clinthera.2019.07.011","article-title":"Insulin glargine U100 improved glycemic control and reduced nocturnal hypoglycemia in patients with type 2 diabetes mellitus and chronic kidney disease stages 3 and 4","volume":"41","author":"Betonico","year":"2019","journal-title":"Clin Ther"},{"key":"10.1016\/j.jcjd.2023.08.003_bib85","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00592-018-1107-1","article-title":"Comparative safety and efficacy of insulin degludec with insulin glargine in type 2 and type 1 diabetes: A meta-analysis of randomized controlled trials","volume":"55","author":"Zhang","year":"2018","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.jcjd.2023.08.003_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2020.107831","article-title":"Target attainment in insulin-naive patients at high risk for hypoglycemia: Results from ACHIEVE Control","volume":"35","author":"Anderson","year":"2021","journal-title":"J\u00a0Diabetes Complications"},{"key":"10.1016\/j.jcjd.2023.08.003_bib87","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2337\/ds20-0079","article-title":"Post hoc analysis evaluating the impact of antihyperglycemic background therapies on attainment of A1C targets without hypoglycemia in the ACHIEVE control pragmatic, real-life study","volume":"34","author":"Bailey","year":"2021","journal-title":"Diabetes Spectrum"},{"key":"10.1016\/j.jcjd.2023.08.003_bib88","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/jama.2017.7115","article-title":"Effect of insulin degludec vs insulin glargine U100 on hypoglycemia in patients with type 1 diabetes: The SWITCH 1 randomized clinical trial","volume":"318","author":"Lane","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jcjd.2023.08.003_bib89","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/dom.14574","article-title":"Comparison of treatment with insulin degludec and glargine U100 in patients with type 1 diabetes prone to nocturnal severe hypoglycaemia: The HypoDeg randomized, controlled, open-label, crossover trial","volume":"24","author":"Pedersen-Bjergaard","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jcjd.2023.08.003_bib90","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/s00125-019-05080-9","article-title":"Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: The randomised, head-to-head CONCLUDE trial","volume":"63","author":"Philis-Tsimikas","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcjd.2023.08.003_bib91","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1007\/s13300-020-00925-8","article-title":"The safety and efficacy of second-generation basal insulin analogues in adults with type 2 diabetes at risk of hypoglycemia and use in other special populations: A narrative review","volume":"11","author":"Cheng","year":"2020","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.jcjd.2023.08.003_bib92","article-title":"Meta-analysis of 11 heterogeneous studies regarding dipeptidyl peptidase 4 inhibitor add-on therapy for type 2 diabetes mellitus patients treated with insulin","volume":"2020","author":"Shibuki","year":"2020","journal-title":"J\u00a0Diabetes Res"},{"key":"10.1016\/j.jcjd.2023.08.003_bib93","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.2337\/dc14-0030","article-title":"Recovery of hypoglycemia awareness in long-standing type 1 diabetes: A multicenter 2\u00a0\u00d7 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS)","volume":"37","author":"Little","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib94","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s40618-021-01674-6","article-title":"Efficacy and safety of closed-loop insulin delivery versus sensor-augmented pump in the treatment of adults with type 1 diabetes: A systematic review and meta-analysis of randomized-controlled trials","volume":"45","author":"Fang","year":"2022","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.jcjd.2023.08.003_bib95","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00592-020-01589-3","article-title":"Effects of real-time continuous glucose monitoring in type 1 diabetes: A meta-analysis of randomized controlled trials","volume":"58","author":"Dicembrini","year":"2021","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.jcjd.2023.08.003_bib96","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s00125-021-05648-4","article-title":"Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: A systematic review of randomised controlled trials and meta-analysis","volume":"65","author":"Teo","year":"2022","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.jcjd.2023.08.003_bib97","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1089\/dia.2021.0503","article-title":"Benefit of continuous glucose monitoring (CGM) in reducing hypoglycemia is sustained through 12 months of use among older adults with type 1 diabetes","volume":"Jun.24","author":"Miller","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jcjd.2023.08.003_bib98","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1210\/jc.2018-00142","article-title":"Hypoglycemic exposure and risk of asymptomatic hypoglycemia in type 1 diabetes assessed by continuous glucose monitoring","volume":"103","author":"Henriksen","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jcjd.2023.08.003_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2021.108106","article-title":"Randomized comparison of self-monitored blood glucose (BGM) versus continuous glucose monitoring (CGM) data to optimize glucose control in type 2 diabetes","volume":"36","author":"Bergenstal","year":"2022","journal-title":"J\u00a0Diabetes Complications"},{"key":"10.1016\/j.jcjd.2023.08.003_bib100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s13300-016-0223-6","article-title":"Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: A multicenter, open-label randomized controlled trial","volume":"8","author":"Haak","year":"2017","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.jcjd.2023.08.003_bib101","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00125-020-05370-7","article-title":"Potential diabetes overtreatment and risk of adverse events among older adults in Ontario: A population-based study","volume":"64","author":"Lega","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcjd.2023.08.003_bib102","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jamainternmed.2016.2275","article-title":"Intensive treatment and severe hypoglycemia among adults with type 2 diabetes","volume":"176","author":"McCoy","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jcjd.2023.08.003_bib103","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2337\/cd20-0042","article-title":"Time in range: How to measure it, how to report it, and its practical application in clinical decision-making","volume":"38","author":"Wright","year":"2020","journal-title":"Clin Diabetes"},{"key":"10.1016\/j.jcjd.2023.08.003_bib104","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.2337\/diabetes.47.9.1472","article-title":"Brief twice-weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in type 1 diabetes mellitus","volume":"47","author":"Ovalle","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.jcjd.2023.08.003_bib105","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2337\/diab.42.11.1683","article-title":"Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM","volume":"42","author":"Fanelli","year":"1993","journal-title":"Diabetes"},{"key":"10.1016\/j.jcjd.2023.08.003_bib106","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.2337\/diab.43.12.1426","article-title":"Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM","volume":"43","author":"Dagogo-Jack","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.jcjd.2023.08.003_bib107","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/BF00399801","article-title":"Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM","volume":"37","author":"Fanelli","year":"1994","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcjd.2023.08.003_bib108","doi-asserted-by":"crossref","first-page":"866","DOI":"10.2337\/diacare.22.5.866","article-title":"Durable reversal of hypoglycemia unawareness in type 1 diabetes","volume":"22","author":"Dagogo-Jack","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib109","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0002-9343(94)90349-2","article-title":"Recovery of epinephrine response but not hypoglycemic symptom threshold after intensive therapy in type 1 diabetes","volume":"97","author":"Davis","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.jcjd.2023.08.003_bib110","first-page":"71","article-title":"Improved counter-regulatory hormonal and symptomatic responses to hypoglycemia in patients with insulin-dependent diabetes mellitus after 3 months of less strict glycemic control","volume":"19","author":"Liu","year":"1996","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.jcjd.2023.08.003_bib111","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2337\/diacare.18.3.321","article-title":"Improvement of impaired counterregulatory hormone response and symptom perception by short-term avoidance of hypoglycemia in IDDM","volume":"18","author":"Lingenfelser","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib112","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1207\/s15327558ijbm1104_4","article-title":"Hypoglycemia anticipation, awareness and treatment training (HAATT) reduces occurrence of severe hypoglycemia among adults with type 1 diabetes mellitus","volume":"11","author":"Cox","year":"2004","journal-title":"Int J Behav Med"},{"key":"10.1016\/j.jcjd.2023.08.003_bib113","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2337\/dc13-1245","article-title":"A\u00a0psychoeducational program to restore hypoglycemia awareness: The DAFNE-HART pilot study","volume":"37","author":"De Zoysa","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib114","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.2337\/diacare.22.7.1022","article-title":"Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes","volume":"22","author":"Kinsley","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib115","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1007\/s00125-020-05244-y","article-title":"A\u00a0single-blind, randomised, crossover study to reduce hypoglycaemia risk during postprandial exercise with closed-loop insulin delivery in adults with type 1 diabetes: Announced (with or without bolus reduction) vs unannounced exercise strategies","volume":"63","author":"Tagougui","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcjd.2023.08.003_bib116","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.2337\/dc20-0112","article-title":"Real-time CGM is superior to flash glucose monitoring for glucose control in type 1 diabetes: The CORRIDA Randomized Controlled Trial","volume":"43","author":"Haskova","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib117","first-page":"808","article-title":"Impact of continuous glucose monitoring on improving emotional well-being among adults with type 1 diabetes mellitus: A systematic review and meta-analysis","volume":"131","author":"K\u0142ak","year":"2021","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.jcjd.2023.08.003_bib118","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2337\/diacare.18.4.523","article-title":"A\u00a0multicenter evaluation of blood glucose awareness training-II","volume":"18","author":"Cox","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib119","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.2337\/dc15-1988","article-title":"Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia","volume":"39","author":"Hering","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib120","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s11892-012-0294-3","article-title":"Recovery of endocrine function after islet and pancreas transplantation","volume":"12","author":"Rickels","year":"2012","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.jcjd.2023.08.003_bib121","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S2213-8587(22)00114-0","article-title":"Pancreatic islet transplantation in type 1 diabetes: 20-year experience from a single-centre cohort in Canada","volume":"10","author":"Marfil-Garza","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jcjd.2023.08.003_bib122","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2337\/diab.46.2.249","article-title":"Pancreas transplantation restores epinephrine response and symptom recognition during hypoglycemia in patients with long-standing type I diabetes and autonomic neuropathy","volume":"46","author":"Kendall","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.jcjd.2023.08.003_bib123","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/00007890-200109270-00021","article-title":"Restored hypoglycemic counterregulation is stable in successful pancreas transplant recipients for up to 19 years after transplantation","volume":"72","author":"Paty","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.jcjd.2023.08.003_bib124","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2337\/diab.43.5.661","article-title":"Pancreas transplantation in diabetic humans normalizes hepatic glucose production during hypoglycemia","volume":"43","author":"Barrou","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.jcjd.2023.08.003_bib125","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archinte.1990.00390150083016","article-title":"The search for an optimized treatment of hypoglycemia. Carbohydrates in tablets, solution, or gel for the correction of insulin reactions","volume":"150","author":"Slama","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jcjd.2023.08.003_bib126","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2337\/diacare.16.8.1131","article-title":"Alanine and terbutaline in treatment of hypoglycemia in IDDM","volume":"16","author":"Wiethop","year":"1993","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib127","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1001\/jama.1984.03350240024032","article-title":"Treatment of insulin reactions in diabetics","volume":"252","author":"Brodows","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.jcjd.2023.08.003_bib128","series-title":"Medical Management of Type 1 Diabetes","first-page":"134","year":"1998"},{"key":"10.1016\/j.jcjd.2023.08.003_bib129","first-page":"117","article-title":"The role of dietary sugars in diabetes mellitus","volume":"15","year":"1991","journal-title":"Beta Release"},{"key":"10.1016\/j.jcjd.2023.08.003_bib130","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1001\/jama.1978.03290150057025","article-title":"Bioactivity of instant glucose. Failure of absorption through oral mucosa","volume":"240","author":"Gunning","year":"1978","journal-title":"JAMA"},{"key":"10.1016\/j.jcjd.2023.08.003_bib131","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2337\/diacare.17.7.734","article-title":"Hypoglycemia","volume":"17","author":"Cryer","year":"1994","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib132","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00592-020-01483-y","article-title":"Intranasal versus injectable glucagon for hypoglycemia in type 1 diabetes: Systematic review and meta-analysis","volume":"57","author":"Pontiroli","year":"2020","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.jcjd.2023.08.003_bib133","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/dom.14019","article-title":"Nasal glucagon as a viable alternative for treating insulin-induced hypoglycaemia in Japanese patients with type 1 or type 2 diabetes: A phase 3 randomized crossover study","volume":"22","author":"Matsuhisa","year":"2020","journal-title":"Diabetes Obesity Metab"},{"key":"10.1016\/j.jcjd.2023.08.003_bib134","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1089\/dia.2016.0460","article-title":"Faster use and fewer failures with needle-free nasal glucagon versus injectable glucagon in severe hypoglycemia rescue: A simulation study","volume":"19","author":"Yale","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jcjd.2023.08.003_bib135","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2337\/dc16-1472","article-title":"Low-carbohydrate diet impairs the effect of glucagon in the treatment of insulin-induced mild hypoglycemia: A randomized crossover study","volume":"40","author":"Ranjan","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib136","series-title":"Glucagon [product monograph]","year":"2007"},{"key":"10.1016\/j.jcjd.2023.08.003_bib137","series-title":"GlucaGen\u00ae (glucagon) [product monograph]","year":"2002"},{"key":"10.1016\/j.jcjd.2023.08.003_bib138","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.2337\/diacare.26.6.1902","article-title":"Hypoglycemia in diabetes","volume":"26","author":"Cryer","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib139","doi-asserted-by":"crossref","first-page":"2464.e71","DOI":"10.2337\/dc12-1205","article-title":"Insulin degludec versus insulin glargine in insulin-naive patients with type 2 diabetes: A 1-year, randomized, treat-to-target trial (BEGIN Once Long)","volume":"35","author":"Zinman","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.08.003_bib140","doi-asserted-by":"crossref","first-page":"385e97","DOI":"10.1503\/cmaj.081041","article-title":"Efficacy and safety of insulin analogues for the management of diabetes mellitus: A meta-analysis","volume":"180","author":"Singh","year":"2009","journal-title":"CMAJ"},{"key":"10.1016\/j.jcjd.2023.08.003_bib141","first-page":"CD005613","article-title":"Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus","volume":"2","author":"Horvath","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcjd.2023.08.003_bib142","doi-asserted-by":"crossref","first-page":"184.e9","DOI":"10.1016\/j.diabres.2008.04.007","article-title":"Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: A meta-analysis","volume":"81","author":"Monami","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jcjd.2023.08.003_bib143","doi-asserted-by":"crossref","first-page":"649e62","DOI":"10.1007\/s00592-014-0698-4","article-title":"Systematic review and meta-analysis of randomized clinical trials comparing efficacy and safety outcomes of insulin glargine with NPH insulin, premixed insulin preparations or with insulin detemir in type 2 diabetes mellitus","volume":"52","author":"Rys","year":"2015","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.jcjd.2023.08.003_bib144","doi-asserted-by":"crossref","first-page":"175.e84","DOI":"10.1111\/dom.12032","article-title":"Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: A pre-planned meta-analysis of phase 3 trials","volume":"15","author":"Ratner","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jcjd.2023.08.003_bib145","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jama.2013.277818","article-title":"Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: A randomized clinical trial","volume":"310","author":"Ly","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jcjd.2023.08.003_bib146","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJMoa1303576","article-title":"Threshold-based insulin-pump\u00a0interruption for reduction of hypoglycemia","volume":"369","author":"Bergenstal","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcjd.2023.08.003_bib147","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S2213-8587(16)30193-0","article-title":"Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): A randomised, open-label, crossover trial","volume":"4","author":"van Beers","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jcjd.2023.08.003_bib148","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/ajt.13536","article-title":"A\u00a0comparative analysis of the safety, efficacy, and cost of islet versus pancreas transplantation in nonuremic patients with type 1 diabetes","volume":"16","author":"Moassesfar","year":"2016","journal-title":"Am J Transplant"}],"container-title":["Canadian Journal of Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267123001892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267123001892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:39:30Z","timestamp":1761493170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499267123001892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":148,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1499267123001892"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjd.2023.08.003","relation":{},"ISSN":["1499-2671"],"issn-type":[{"value":"1499-2671","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypoglycemia in Adults","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjd.2023.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Canadian Diabetes Association.","name":"copyright","label":"Copyright"}]}}